DND Technologies, Inc. DNDT · Stock Open DND Technologies, Inc. in new tab
DND Technologies, Inc. Analysis (DNDT)
Is DND Technologies, Inc. a good investment? DND Technologies, Inc. (DNDT) is currently trading at 0.1550 USD.
Investor FAQ
Does DND Technologies, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is DND Technologies, Inc.?
DND Technologies, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.
Community Discussion